Email Address / User Name:
:Remember Login

Register Here!

Our Services

Naked Short List

by Date

by Exchange

Our Press Releases

SEC & Other Articles

Symbol :

OFF LIST - 498 consecutive market days: OFF LIST as of 04/26/2012 Through 04/17/2014

Current Quote*

Last: $2.990
Volume: 400

As Of: 2014-04-18 12:10:00 ET
*Quotes delayed by 20min.

Transcept Pharmaceuticals Inc (NASDAQ:TSPT)
Industry: Healthcare

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product comprises Intermezzo sublingual tablet C-IV, a sublingual formulation of zolpidem for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States, as well as granted Purdue Pharmaceutical Products, L.P. the right to negotiate for the commercialization of Intermezzo in Mexico and Canada. Transcept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Point Richmond, California.

Realtime Data

BuyIns.Net Releases for Symbol TSPT

3 Month

6 Month

1 Year